As a multifunctional transcription factor, CTCF was reported to be involved in the initiation of multiple cancers, including breast cancer [18], hepatocellular carcinoma [22], lung cancer [14], prostate cancer [23], etc., which could be attributed to the abnormal expression of CTCF or the dysregulation of its target genes. The gene discussed is CTCF; the disease is breast carcinoma.